Your browser doesn't support javascript.
loading
Ofatumumab plus HyperCVAD/HD-MA induction leads to high rates of minimal residual disease negativity in patients with newly diagnosed mantle cell lymphoma: Results of a phase 2 study.
Torka, Pallawi; Akhtar, Othman S; Reddy, Nishitha M; Baysal, Bora E; Kader, Angela; Groman, Adrienne; Nichols, Jenna; Mavis, Cory; Tario, Joseph D; Block, AnneMarie W; Sait, Sheila N J; Ghione, Paola; Sundaram, Suchitra; Przespolewski, Eugene R; Mohr, Alice; Lund, Ian; Kostrewa, Jessica; McWhite, Kenneth; DeMarco, Joseph; Johnson, Michael; Darrall, Andrea; Thomas-Talley, Rosh-Neke; Wallace, Paul K; Neppalli, Vishala; Hutson, Alan; Hernandez-Ilizaliturri, Francisco J.
Afiliação
  • Torka P; Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Akhtar OS; Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Reddy NM; Vanderbilt University Medical Center, Nashville, Tennessee.
  • Baysal BE; Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Kader A; Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Groman A; Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Nichols J; Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Mavis C; Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Tario JD; Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Block AW; Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Sait SNJ; Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Ghione P; Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Sundaram S; Icahn School of Medicine at Mount Sinai, New York, New York.
  • Przespolewski ER; Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Mohr A; Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Lund I; Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Kostrewa J; Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • McWhite K; Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • DeMarco J; Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Johnson M; Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Darrall A; Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Thomas-Talley RN; Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Wallace PK; Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Neppalli V; University of Manitoba, Winnipeg, Manitoba, Canada.
  • Hutson A; Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Hernandez-Ilizaliturri FJ; Roswell Park Comprehensive Cancer Center, Buffalo, New York.
Cancer ; 128(8): 1595-1604, 2022 04 15.
Article em En | MEDLINE | ID: mdl-35157306
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Linfoma de Célula do Manto / Anticorpos Monoclonais Humanizados Tipo de estudo: Diagnostic_studies Limite: Adult / Humans / Middle aged Idioma: En Revista: Cancer Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Linfoma de Célula do Manto / Anticorpos Monoclonais Humanizados Tipo de estudo: Diagnostic_studies Limite: Adult / Humans / Middle aged Idioma: En Revista: Cancer Ano de publicação: 2022 Tipo de documento: Article